Daytime High Blood Pressure Cold And Flu Relief Liquid Filled Softgels Capsule, Liquid Filled
NDC Package 76281-609-03
Package Information
Daytime High Blood Pressure Cold And Flu Relief Liquid Filled Softgels (acetaminophen, dextromethrophan hbr) capsules is usesTemporarily relieves common cold/flu symptoms:. This formulation utilizes a capsule, liquid filled delivery system. Marketed by Aptapharma Inc., this product is identified by NDC 76281-609 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 1867684 - acetaminophen 325 MG / dextromethorphan HBr 10 MG Oral Capsule
- RxCUI: 1867684 - acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG Oral Capsule
- RxCUI: 1867684 - APAP 325 MG / Dextromethorphan Hydrobromide 10 MG Oral Capsule
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 76281 - Aptapharma Inc.
- 76281-609 - Daytime High Blood Pressure Cold And Flu Relief Liquid Filled Softgels
- 76281-609-03 - 2 BLISTER PACK in 1 CARTON / 12 CAPSULE, LIQUID FILLED in 1 BLISTER PACK
- 76281-609 - Daytime High Blood Pressure Cold And Flu Relief Liquid Filled Softgels
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 76281-609-03 identifies a specific commercial package of 2 blister pack in 1 carton / 12 capsule, liquid filled in 1 blister pack of Daytime High Blood Pressure Cold And Flu Relief Liquid Filled Softgels, a human over the counter drug labeled by Aptapharma Inc.. This capsule, liquid filled is formulated for oral use and contains acetaminophen; dextromethorphan hydrobromide as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Aptapharma Inc. on January 01, 2026. The current certification is valid through December 31, 2027.
How is this Aptapharma Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 76281060903. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.